Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cost-effective Treatment
100%
Hypertensive Patients
100%
Pyridoxal 5′-phosphate
100%
Treatment Candidates
100%
Angiotensin II (Ang II)
90%
Angiotensin
72%
Blood Pressure
63%
Wistar Rats
27%
Hypertension
18%
Angiotensin II Type 1 Receptor (AT1R)
18%
Post-translational Modification
18%
Vascular Smooth muscle Cells
18%
Effective Compounds
18%
Vitamin B
18%
Binding Affinity
18%
Spontaneously Hypertensive Rats
18%
Calcium Ion
18%
Isolated Perfused Rat Kidney
18%
Hypertensive
9%
Perfusion Pressure
9%
Phosphorus Intake
9%
INIS
phosphates
100%
patients
100%
cost
100%
angiotensin
100%
pyridoxal
100%
rats
52%
blood pressure
36%
hypertension
10%
drugs
10%
receptors
10%
comparative evaluations
10%
muscles
10%
kidneys
10%
affinity
10%
modifications
10%
vitamins
10%
calcium ions
10%
values
5%
intake
5%
peptides
5%
bioassay
5%
Medicine and Dentistry
Health Care Cost
100%
Angiotensin II
100%
Pyridoxal 5 Phosphate
100%
Angiotensin
72%
Blood Pressure
63%
Receptor
18%
Calcium Ion
18%
Binding Affinity
18%
Vitamin B Group
18%
Vascular Smooth Muscle Cell
18%
Spontaneously Hypertensive Rat
18%
Post-Translational Modification
18%
Bioassay
9%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin II
100%
Pyridoxal 5 Phosphate
100%
Angiotensin
72%
Wistar Kyoto Rat
27%
Receptor
18%
Calcium Ion
18%
Vitamin B Group
18%
Spontaneously Hypertensive Rat
18%
Neuroscience
Pyridoxal Phosphate
100%
Angiotensin II
81%
Angiotensin
72%
Posttranslational Modification
18%
B Vitamin
18%
Angiotensin II Receptor Type 1
18%
Binding Affinity
18%
Vascular Smooth Muscle
18%
Hypertension
18%
Biochemistry, Genetics and Molecular Biology
Angiotensin
100%
Pyridoxal Phosphate
100%
Blood Pressure
41%
Wistar Kyoto Rat
17%
B Vitamin
11%
Posttranslational Modification
11%
Angiotensin II Receptor Type 1
11%
Binding Affinity
11%
Spontaneously Hypertensive Rat
11%
Calcium Ion
11%
Perfusion Pressure
5%